Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Celgene (CELG)

Add to Watchlists
Create an Alert
145.05 -1.59  -1.08% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
CELG Price Chart
View All Events

CELG Events

Date Type Description
Apr 24 Misc Q1 2014 Celgene Corporation Earnings Conference Call
Apr 24 Earnings Q1 2014 Celgene Corporation Earnings Results. Estimate: 1.43.
Jan 30 Misc Q4 2013 Celgene Corp. Earnings Conference Call
Jan 30 Earnings Q4 2013 Celgene Corp. Earnings Result. Estimate: 1.39.
Oct 24 Misc Will Host an Investor Webcast Event From the American College of Rheumatology Meeting on October 27, 2013 Summit, n.j.--(business Wire)--oct. 1, 2013-- Celgene Corporation (Nasdaq:celg) Will Host a Conference Call and Live Audio Webcast on Thursday,
Oct 24 Earnings Celgene Corporation to Announce Third Quarter 2013 Results on October 24, 2013. Estimate: 1.38.
Jul 25 Misc Summit, n.j.--(business Wire)--jul. 8, 2013-- Celgene Corporation (Nasdaq: Celg) Will Host a Conference Call and Live Audio Webcast on Thursday, July 25, 2013 at 9 a.m. Et to Discuss Second Quarter 2013 Financial and Operational Results. The Webcast
Jul 25 Earnings Celgene Corporation to Announce Second Quarter 2013 Results on July 25, 2013. Estimate: 1.31.
May 06 Misc Celgene Corp. Analyst Meeting
Apr 25 Misc Summit, n.j.--(business Wire)--apr. 3, 2013-- Celgene Corporation (Nasdaq: Celg) Senior Management Will Host a Conference Call and Live Audio Webcast on Thursday, April 25, 2013 at 9 a.m. Et to Discuss the Company’s First Quarter 2013 Financial and O
View All Performance Charts

CELG Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Celgene is up 14.36% over the last year vs S&P 500 Total Return up 22.59%, Amgen up 1.74%, and Gilead Sciences up 36.65%.

Get Quote for

PDF Report for CELG

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CELG Pro Report PDF
Advertisement

Portfolio Strategies Featuring CELG

Did Celgene make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CELG Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Celgene Corporation is a manufacturer of drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major products are Thalamid (thalidomide), which is approved for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum ("ENL"), as well as in combination with dexamethasone for patients with newly diagnosed multiple myeloma, and Revlimid (lenalidomide), for which the company has received FDA and EMEA approval in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Both Thalamid and Revlimid are sold through proprietary risk-management distribution programs to ensure safe and appropriate use of these pharmaceuticals. Celgene Corporation has strategic collaboration with Acceleron Pharma, Inc. The company was founded in 1980.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CELG 145.05 -1.59 -1.08% 58.89B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.